Americans spend more than $100 billion a year to treat low back pain,” said Dr. Jason Huang, MD, chairman of neurosurgery for Baylor Scott & White Health Center. That price may start to come down and lower back pain degeneration may decrease as new research is being presented to aid those suffering from low back disc pain. This potential development in technology and therapies would allow for new disc treatments for disc denigration and may potentially reverse its course.
In previous research, scientists have found a gene that can be linked to tumor formation and disease progression. This research gives insight into the molecular mechanisms involved in the breakdown of soft tissue discs in the spine. Through this understanding, researchers can now develop pharmacological agents and other forms of injectable therapies which may block the degenerative process and promote a reverse change or a remodeling process. The next step in this research will apply findings of the SMURF2 research to human tissue. Intervention medication treatments in human clinical trials are scheduled at Baylor Scott & White Research Institute in Temple, Texas. This is also where this research was discovered.
Just imagine the relief people will feel as their pain management doctors begin to share this good news. Over the years, patients have managed degenerative disc disease by using non-surgical approaches and self-care. As time goes on, the disc starts to become stiffer with age and thus its motion lessen and the pain may lessen as well. Patients avoid surgical intervention as it can be extensive and a long recovery process. As scientists are able to understand DNA genes and what they may trigger, we as a society may someday have the ability to proactively attack harmful genes in our body. Dr. Jonathan Newton of North Atlanta Spine & Pain Care cares about the pain his patients experience. That is why it is critical for doctors to stay informed about the latest research so their patients can return to a pain-free life again.